Global Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) Therapeutics Pipeline Review 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with the latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) and special features on late-stage and discontinued projects.

The report enhances decision-making capabilities and helps to create effective counter-strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) Overview
  3. Therapeutics Development
  4. Pipeline Products for Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Overview
  5. Pipeline Products for Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Comparative Analysis
  6. Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Therapeutics under Development by Companies
  7. Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Therapeutics under Investigation by Universities/Institutes
  8. Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) Products Glance
  9. Late-Stage Products
  10. Clinical-Stage Products
  11. Early-Stage Products
  12. Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Products under Development by Companies
  13. Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Products under Investigation by Universities/Institutes
  14. Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Companies Involved in Therapeutics Development
  • Daiichi Sankyo Company, Limited
  • Galmed Pharmaceuticals Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Novartis AG
  • Sanofi
  • Xenon Pharmaceuticals Inc.

For more information visit http://www.researchandmarkets.com/research/cdthz5/stearoylcoa.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Enzymes

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Enzymes